DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Hurvitz SA, Martin M, Symmans WF. et al.
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol 2018;
19: 115-126
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.